We are live on ! Find out more
AA

AlphaCentric Advisors Portfolio holdings

AUM $118M
This Fund
S&P 500
This Quarter Est. Return
+6.03%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$240M
AUM Growth
+$33.2M
Cap. Flow
+$24.9M
Cap. Flow %
10.4%
Top 10 Hldgs %
83.63%
Holding
243
New
78
Increased
59
Reduced
41
Closed
38

Sector Composition

Rank Sector Weight
1 Miscellaneous 67.02%
2 Real Estate 16.47%
3 Healthcare 9.97%
4 Technology 2.87%
5 Industrials 1.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNK icon
51
State Street SPDR Bloomberg High Yield Bond ETF
JNK
$6.85B
$259K 0.11%
2,381
+7
+0.3% +$746
SHYG icon
52
iShares 0-5 Year High Yield Corporate Bond ETF
SHYG
$7.75B
$258K 0.11%
5,681
+21
+0.4% +$938
ITCI
53
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$254K 0.11%
8,000
+7,450
+1,355% +$196K
VRTX icon
54
Vertex Pharmaceuticals
VRTX
$138B
$248K 0.1%
1,050
+1,040
+10,400% +$239K
TECX
55
Tectonic Therapeutic
TECX
$601M
$247K 0.1%
+1,475
New +$262K
VIVS
56
VivoSim Labs
VIVS
$3.73M
$246K 0.1%
+1,667
New +$190K
HPE icon
57
Hewlett Packard
HPE
$69B
$241K 0.1%
20,370
-1,331
-6% -$14K
LKFT
58
Lakefront Biotherapeutics American Depositary Shares
LKFT
$1.87B
$238K 0.1%
+2,400
New +$293K
ADAP
59
DELISTED
Adaptimmune Therapeutics
ADAP
$237K 0.1%
44,000
+39,800
+948% +$216K
OYST
60
DELISTED
Oyster Point Pharma, Inc. Common Stock
OYST
$226K 0.09%
+12,000
New +$259K
COGT icon
61
Cogent Biosciences
COGT
$6.03B
$221K 0.09%
+19,700
New +$216K
INCY icon
62
Incyte
INCY
$25.7B
$217K 0.09%
+2,500
New +$216K
VLO icon
63
Valero Energy
VLO
$107B
$212K 0.09%
3,740
-224
-6% -$11K
ARNA
64
DELISTED
Arena Pharmaceuticals Inc
ARNA
$211K 0.09%
+2,750
New +$206K
ALLK
65
DELISTED
Allakos
ALLK
$210K 0.09%
+1,500
New +$156K
CVS icon
66
CVS Health
CVS
$124B
$207K 0.09%
3,027
-211
-7% -$13.7K
IPFF
67
DELISTED
iShares International Preferred Stock ETF
IPFF
$199K 0.08%
12,776
-176
-1% -$2.59K
VNQI icon
68
Vanguard Global ex-US Real Estate ETF
VNQI
$3.49B
$197K 0.08%
+3,629
New +$187K
PFF icon
69
iShares Preferred and Income Securities ETF
PFF
$12.9B
$196K 0.08%
5,089
-42
-0.8% -$1.57K
VNQ icon
70
Vanguard Real Estate ETF
VNQ
$37.9B
$194K 0.08%
+2,286
New +$190K
FUSN
71
DELISTED
Fusion Pharmaceuticals Inc. Common Shares
FUSN
$194K 0.08%
16,500
+12,700
+334% +$160K
QURE icon
72
uniQure
QURE
$3.09B
$181K 0.08%
5,000
+3,000
+150% +$127K
COLL icon
73
Collegium Pharmaceutical
COLL
$766M
$180K 0.08%
9,000
+6,600
+275% +$129K
MRK icon
74
Merck
MRK
$371B
$180K 0.08%
2,306
+1,730
+300% +$132K
IDYA icon
75
IDEAYA Biosciences
IDYA
$3.85B
$175K 0.07%
12,500
+11,000
+733% +$149K

Similar funds

AlphaCentric Advisors's Q4 2020 Portfolio in Review

As of Q4 2020, AlphaCentric Advisors held 243 positions worth $240M, up 16% from $207M the previous quarter. Its ten largest holdings account for 84% of the portfolio.

AlphaCentric Advisors deployed $24.9M of net new capital in Q4 2020, opening 78 new positions and adding to 59 existing holdings. Its largest new stake was Nano Dimension: 125,000 shares worth $1.14M.

By sector, the portfolio is most concentrated in Miscellaneous at 67% of assets, down from 71% a quarter earlier, followed by Real Estate and Healthcare.

On the sell side, the largest reduction was iShares 1-3 Year Treasury Bond ETF, an estimated $3.98M trimmed.

  • AlphaCentric Advisors's largest Q4 2020 buy was Nano Dimension: 125,000 shares worth $1.14M.
  • AlphaCentric Advisors added most to Vanguard Mortgage-Backed Securities ETF in Q4 2020, an estimated $14.9M increase.
  • AlphaCentric Advisors's biggest Q4 2020 reduction was iShares 1-3 Year Treasury Bond ETF, cutting an estimated $3.98M.
  • AlphaCentric Advisors fully exited FLIR Systems, Inc. (DE) Common Stock in Q4 2020, selling an estimated $896K.
  • AlphaCentric Advisors's ten largest holdings make up 84% of its $240M portfolio in Q4 2020.
  • AlphaCentric Advisors opened 78 new positions and closed 38 in Q4 2020.
  • AlphaCentric Advisors's portfolio value rose 16% quarter-over-quarter to $240M.

Based on AlphaCentric Advisors's 13F filing for Q4 2020, filed 11 Mar 2022.